Key result
Corrective surgery for truncus arteriosus resulted in 23 deaths (25%) in the first 30 days among 92 patients, with 97% of survivors eventually achieving symptom-free or NYHA class II status.
Why the study?
What are the early and late outcomes of surgical repair in patients with truncus arteriosus?
Cohort (n=92)
What are the early and late outcomes of surgical repair in patients with truncus arteriosus?
Surgical repair of truncus arteriosus is associated with acceptable operative mortality and excellent long-term functional outcomes for survivors.
May support repair despite early risks; leaves open need for strategies to reduce perioperative mortality in larger cohorts.
Ninety-two patients had corrective operation for truncus arteriosus between 1967 and 1975. During the first 30 days after surgery, 23 patients died. No significant differences appear between early mortality and sex, type of truncus, variations in pulmonary arterial anatomy, truncal valve regurgitation, associated anomalies, previous operation, or duration of extracorporeal circulation. Greater risk is probably encountered with the higher but still operable levels of pulmonary resistance. Reoperation has been required in three patients. Fifty-nine percent of survivors are symptom-free, with all but two of the remainder (38%) being in NYHA functional class II. The late result is suggestively less satisfactory in patients with significant preoperative truncal valve regurgitation. Some late complications related to deterioration of the earlier aortic homograft conduit may be avoided by use of a porcine valve Dacron conduit. The current operative mortality of 9%, and the well-being of 97% of surviving patients suggest the continued advisability of recommending operation for appropriate patients.
No takes yet. Share an insight, caveat, or question.
Marcelletti et al. (1977) conducted a cohort in Truncus arteriosus (n=92). Corrective surgical repair was evaluated on Early mortality (first 30 days after surgery). Corrective surgery for truncus arteriosus resulted in 23 deaths (25%) in the first 30 days among 92 patients, with 97% of survivors eventually achieving symptom-free or NYHA class II status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: